BACKGROUND: In 1997 we launched a prospective program of transanal endoscopic microsurgery (TEM) for the treatment of rectal cancer. METHODS: Suitability for TEM was based on endorectal ultrasound results, classified as follows: (I) benign tumors; (II) adenocarcinomas uT0 and uT1 with uN0; (III) adenocarcinomas uT2- uN0, low histological grade with intention to cure; and (IV) advanced stage adenocarcinomas with palliative care RESULTS: Transanal endoscopic microsurgery was performed in 218 patients: 122 adenomas, and 96 adenocarcinomas: group II-72, group III-19, and group IV-5. Follow-up was >24 months (median 59 months) in 61 patients. Nine were lost to follow-up, and so 52 patients were studied: group II-38, group III-11, and group IV-3. The Kaplan-Meier probability of nonrecurrence of adenocarcinoma by group was 93% in tumors in situ (Tis) and T1; and 77.8% in T2. The Kaplan-Meier probability of survival by group was 100% in Tis and T1 and 82% in T2. CONCLUSIONS: Rates of recurrence and long-term survival in Tis and T1 adenocarcinomas treated with TEM are similar to those in previously published reports using conventional surgery. Further studies are required in T2 adenocarcinomas to determine a definitive strategy.
BACKGROUND: In 1997 we launched a prospective program of transanal endoscopic microsurgery (TEM) for the treatment of rectal cancer. METHODS: Suitability for TEM was based on endorectal ultrasound results, classified as follows: (I) benign tumors; (II) adenocarcinomas uT0 and uT1 with uN0; (III) adenocarcinomasuT2- uN0, low histological grade with intention to cure; and (IV) advanced stage adenocarcinomas with palliative care RESULTS: Transanal endoscopic microsurgery was performed in 218 patients: 122 adenomas, and 96 adenocarcinomas: group II-72, group III-19, and group IV-5. Follow-up was >24 months (median 59 months) in 61 patients. Nine were lost to follow-up, and so 52 patients were studied: group II-38, group III-11, and group IV-3. The Kaplan-Meier probability of nonrecurrence of adenocarcinoma by group was 93% in tumors in situ (Tis) and T1; and 77.8% in T2. The Kaplan-Meier probability of survival by group was 100% in Tis and T1 and 82% in T2. CONCLUSIONS: Rates of recurrence and long-term survival in Tis and T1 adenocarcinomas treated with TEM are similar to those in previously published reports using conventional surgery. Further studies are required in T2 adenocarcinomas to determine a definitive strategy.
Authors: Dieter Hahnloser; Bruce G Wolff; David W Larson; Jennifer Ping; Santhat Nivatvongs Journal: Dis Colon Rectum Date: 2005-03 Impact factor: 4.585
Authors: X Serra-Aracil; L Mora-Lopez; M Alcantara-Moral; C Corredera-Cantarin; C Gomez-Diaz; S Navarro-Soto Journal: Tech Coloproctol Date: 2013-06-28 Impact factor: 3.781
Authors: Britt J P Hupkens; Monique Maas; Milou H Martens; Willem M L L G Deserno; Jeroen W A Leijtens; Patty J Nelemans; Frans C H Bakers; Doenja M J Lambregts; Geerard L Beets; Regina G H Beets-Tan Journal: Eur Radiol Date: 2017-06-30 Impact factor: 5.315
Authors: X Serra-Aracil; R Flores-Clotet; L Mora-López; A Pallisera-Lloveras; S Serra-Pla; S Navarro-Soto Journal: Tech Coloproctol Date: 2019-08-28 Impact factor: 3.781
Authors: Angelo Restivo; Luigi Zorcolo; Giuseppe D'Alia; Francesca Cocco; Andrea Cossu; Francesco Scintu; Giuseppe Casula Journal: Int J Colorectal Dis Date: 2015-08-23 Impact factor: 2.571
Authors: John Marks; George Nassif; Henry Schoonyoung; Al DeNittis; Eric Zeger; Mohammed Mohiuddin; Gerald Marks Journal: Surg Endosc Date: 2013-09-21 Impact factor: 4.584
Authors: Mario Morino; Marco Ettore Allaix; Federico Famiglietti; Mario Caldart; Alberto Arezzo Journal: Surg Endosc Date: 2012-06-21 Impact factor: 4.584
Authors: Xavier Serra-Aracil; Laura Mora-Lopez; Manel Alcantara-Moral; Aleidis Caro-Tarrago; Carlos Javier Gomez-Diaz; Salvador Navarro-Soto Journal: World J Gastroenterol Date: 2014-09-07 Impact factor: 5.742
Authors: X Serra-Aracil; S Serra-Pla; L Mora-Lopez; A Pallisera-Lloveras; M Labro-Ciurans; S Navarro-Soto Journal: Surg Endosc Date: 2018-06-22 Impact factor: 4.584